Form 4 for EDVA Endovia Health Sciences, Inc.

Accepted 2025-10-20 00:00:00 ET · period of report 2024-04-19 · accession 0001731122-25-001405 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2025-10-20	2024-04-19	EDVA	Caple Frederick William	Dir	A - Grant	$0.00	+1,875	1,875	New	$0
DI	2025-10-20	2024-04-19	EDVA	Caple Frederick William	Dir	A - Grant	$0.00	+15.0K	15.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-04-19	A	A	1,875	$0.00	1,875	I SNS Universal Solutions LLC	—	—	(F1) The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested. (F3) Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. (F4) SNS Universal Solutions LLC is an entity which the Reporting Person controls.
2	Derivative	Stock Options (Right to Buy)	2024-04-19	A	A	15,000	$0.00	15,000	I SNS Universal Solutions LLC	$13.60 · — to 2027-04-19	15,000 Common Stock	(F3) Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. (F2) The stock options shall be exercisable for a 3-year period, and shall vest as follows: 75,000 immediately (125,000 already vested) and 50,000 per quarter for the next 8 quarters. (F4) SNS Universal Solutions LLC is an entity which the Reporting Person controls. (F1) The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested.